Other equities research analysts have also issued research reports about the stock. UBS Group set a €115.00 ($133.72) target price on shares of Hannover Re and gave the company a neutral rating in a research note on Wednesday, October 10th. JPMorgan Chase & Co. set a €117.00 ($136.05) target price on shares of Hannover Re and gave the company a neutral rating in a research note on Thursday, October 11th. DZ Bank reiterated a neutral rating on shares of Hannover Re in a research note on Friday, October 19th. equinet set a €110.00 ($127.91) price objective on shares of Hannover Re and gave the stock a neutral rating in a research note on Friday, October 19th. Finally, Barclays set a €105.20 ($122.33) price objective on shares of Hannover Re and gave the stock a sell rating in a research note on Friday, October 19th. Four research analysts have rated the stock with a sell rating and sixteen have assigned a hold rating to the stock. The company presently has a consensus rating of Hold and a consensus target price of €114.82 ($133.51).
HNR1 traded up €0.50 ($0.58) during trading on Tuesday, reaching €131.50 ($152.91). The company’s stock had a trading volume of 149,612 shares. Hannover Re has a 52-week low of €94.75 ($110.17) and a 52-week high of €116.37 ($135.31).
About Hannover Re
Hannover Rück SE, together with its subsidiaries, provides reinsurance products and services worldwide. It operates through Property & Casualty Reinsurance, and Life & Health Reinsurance segments. The Property & Casualty Reinsurance segment offers specialty lines comprising marine, aviation, facultative, credit, surety, and political risks reinsurance products; and treaty, catastrophe XL, and structured reinsurance, as well as insurance-linked securities.
Receive News & Ratings for Hannover Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hannover Re and related companies with MarketBeat.com's FREE daily email newsletter.